Literature DB >> 8920894

B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice.

D V Serreze1, H D Chapman, D S Varnum, M S Hanson, P C Reifsnyder, S D Richard, S A Fleming, E H Leiter, L D Shultz.   

Abstract

The T lymphocytes mediating autoimmune destruction of pancreatic beta cells in the nonobese diabetic (NOD) mouse model of insulin-dependent diabetes mellitus (IDDM) may be generated due to functional defects in hematopoietically derived antigen-presenting cells (APC). However, it has not been clear which particular subpopulations of APC (B lymphocytes, macrophages, and dendritic cells) contribute to the development and activation of diabetogenic T cells in NOD mice. In the current study we utilized a functionally inactivated immunoglobulin (Ig) mu allele (Ig mu null) to generate a "speed congenic" stock of B lymphocyte-deficient NOD mice that are fixed for linkage markers delineating previously identified diabetes susceptibility (Idd) genes. These B lymphocyte NOD.Ig mu null mice had normal numbers of T cells but were free of overt IDDM and insulitis resistant, while the frequency of disease in the B lymphocyte intact segregants was equivalent to that of standard NOD mice in our colony. Thus, B lymphocytes play a heretofore unrecognized role that is essential for the initial development and/or activation of beta cell autoreactive T cells in NOD mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8920894      PMCID: PMC2192892          DOI: 10.1084/jem.184.5.2049

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

Review 1.  The expression of self antigenic determinants: implications for tolerance and autoimmunity.

Authors:  M J Mamula; J Craft
Journal:  Curr Opin Immunol       Date:  1994-12       Impact factor: 7.486

Review 2.  Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

Authors:  R S Liblau; S M Singer; H O McDevitt
Journal:  Immunol Today       Date:  1995-01

3.  Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes.

Authors:  A Bendelac; C Boitard; P Bedossa; H Bazin; J F Bach; C Carnaud
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

4.  Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.

Authors:  D L Kaufman; M Clare-Salzler; J Tian; T Forsthuber; G S Ting; P Robinson; M A Atkinson; E E Sercarz; A J Tobin; P V Lehmann
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

5.  Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

Authors:  R Tisch; X D Yang; S M Singer; R S Liblau; L Fugger; H O McDevitt
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

Review 6.  Genetic and pathogenic basis of autoimmune diabetes in NOD mice.

Authors:  D V Serreze; E H Leiter
Journal:  Curr Opin Immunol       Date:  1994-12       Impact factor: 7.486

7.  Non-obese diabetic mice hemizygous at the T cell receptor alpha locus are susceptible to diabetes and sialitis.

Authors:  J I Elliott; D M Altmann
Journal:  Eur J Immunol       Date:  1996-04       Impact factor: 5.532

8.  Parameters of tolerance induction by antigen targeted to B lymphocytes.

Authors:  E E Eynon; D C Parker
Journal:  J Immunol       Date:  1993-09-15       Impact factor: 5.422

9.  Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene.

Authors:  D V Serreze; M Prochazka; P C Reifsnyder; M M Bridgett; E H Leiter
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  190 in total

Review 1.  Immune mechanisms that regulate susceptibility to autoimmune type I diabetes.

Authors:  B Singh; T L Delovitch
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  Etiology of autoimmunity.

Authors:  N Sarvetnick
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 3.  Yes T cells, but three different T cells (alphabeta, gammadelta and NK T cells), and also B-1 cells mediate contact sensitivity.

Authors:  P W Askenase
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

4.  CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis.

Authors:  Jean Wu; John Hicks; Jason Borillo; William F Glass; Ya-Huan Lou
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

5.  CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus.

Authors:  Andrew D Vonberg; Maria Acevedo-Calado; Aaron R Cox; Susan L Pietropaolo; Roberto Gianani; Steven K Lundy; Massimo Pietropaolo
Journal:  JCI Insight       Date:  2018-12-06

Review 6.  Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.

Authors:  Laszlo Hegedüs; Terry J Smith; Raymond S Douglas; Claus H Nielsen
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

7.  Mapping of novel autoreactive epitopes of the diabetes-associated autoantigen IA-2.

Authors:  J Seissler; M Schott; N G Morgenthaler; W A Scherbaum
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

8.  Loss and preservation of beta-cell function: two treatment regimes targeting T or B lymphocytes.

Authors:  Anette-G Ziegler; Markus Walter
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

9.  Gut microbial metabolites alter IgA immunity in type 1 diabetes.

Authors:  Juan Huang; James A Pearson; Jian Peng; Youjia Hu; Sha Sha; Yanpeng Xing; Gan Huang; Xia Li; Fang Hu; Zhiguo Xie; Yang Xiao; Shuoming Luo; Chen Chao; F Susan Wong; Zhiguang Zhou; Li Wen
Journal:  JCI Insight       Date:  2020-05-21

Review 10.  Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

Authors:  Daniel F Sheehy; Sean P Quinnell; Arturo J Vegas
Journal:  Biochemistry       Date:  2019-01-17       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.